The Oncology Institute Statistics
Total Valuation
TOI has a market cap or net worth of $395.36 million. The enterprise value is $469.93 million.
Important Dates
The last earnings date was Thursday, May 7, 2026, after market close.
| Earnings Date | May 7, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
TOI has 98.84 million shares outstanding. The number of shares has increased by 30.10% in one year.
| Current Share Class | 98.84M |
| Shares Outstanding | 98.84M |
| Shares Change (YoY) | +30.10% |
| Shares Change (QoQ) | +0.34% |
| Owned by Insiders (%) | 12.66% |
| Owned by Institutions (%) | 39.12% |
| Float | 80.89M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.72 |
| Forward PS | 0.61 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.86 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.47
| Current Ratio | 1.47 |
| Quick Ratio | 1.13 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -4.28 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -12.30% |
| Return on Invested Capital (ROIC) | -57.97% |
| Return on Capital Employed (ROCE) | -36.77% |
| Weighted Average Cost of Capital (WACC) | 6.12% |
| Revenue Per Employee | $851,426 |
| Profits Per Employee | -$46,958 |
| Employee Count | 641 |
| Asset Turnover | 3.29 |
| Inventory Turnover | 25.32 |
Taxes
| Income Tax | -131,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +45.46% in the last 52 weeks. The beta is 0.36, so TOI's price volatility has been lower than the market average.
| Beta (5Y) | 0.36 |
| 52-Week Price Change | +45.46% |
| 50-Day Moving Average | 3.28 |
| 200-Day Moving Average | 3.45 |
| Relative Strength Index (RSI) | 63.90 |
| Average Volume (20 Days) | 1,415,295 |
Short Selling Information
The latest short interest is 8.07 million, so 8.17% of the outstanding shares have been sold short.
| Short Interest | 8.07M |
| Short Previous Month | 8.30M |
| Short % of Shares Out | 8.17% |
| Short % of Float | 9.98% |
| Short Ratio (days to cover) | 4.06 |
Income Statement
In the last 12 months, TOI had revenue of $545.76 million and -$30.10 million in losses. Loss per share was -$0.37.
| Revenue | 545.76M |
| Gross Profit | 82.50M |
| Operating Income | -32.69M |
| Pretax Income | -43.64M |
| Net Income | -30.10M |
| EBITDA | -25.91M |
| EBIT | -32.69M |
| Loss Per Share | -$0.37 |
Full Income StatementBalance Sheet
The company has $30.28 million in cash and $104.86 million in debt, with a net cash position of -$74.58 million or -$0.75 per share.
| Cash & Cash Equivalents | 30.28M |
| Total Debt | 104.86M |
| Net Cash | -74.58M |
| Net Cash Per Share | -$0.75 |
| Equity (Book Value) | -16.29M |
| Book Value Per Share | -0.16 |
| Working Capital | 37.51M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$21.81 million and capital expenditures -$3.91 million, giving a free cash flow of -$25.73 million.
| Operating Cash Flow | -21.81M |
| Capital Expenditures | -3.91M |
| Depreciation & Amortization | 6.78M |
| Net Borrowing | -1.06M |
| Free Cash Flow | -25.73M |
| FCF Per Share | -$0.26 |
Full Cash Flow StatementMargins
Gross margin is 15.12%, with operating and profit margins of -5.99% and -7.97%.
| Gross Margin | 15.12% |
| Operating Margin | -5.99% |
| Pretax Margin | -8.00% |
| Profit Margin | -7.97% |
| EBITDA Margin | -4.75% |
| EBIT Margin | -5.99% |
| FCF Margin | n/a |
Dividends & Yields
TOI does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -30.10% |
| Shareholder Yield | -30.10% |
| Earnings Yield | -7.61% |
| FCF Yield | -6.51% |
Analyst Forecast
The average price target for TOI is $6.67, which is 66.75% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $6.67 |
| Price Target Difference | 66.75% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 3 |
